US Stock MarketDetailed Quotes
NYMXF Nymox Pharmaceutical
- 0.190
- -0.015-7.32%
15min DelayClose Jun 28 16:00 ET
17.72MMarket Cap-3800P/E (TTM)
0.290High0.180Low54.39KVolume0.180Open0.205Pre Close12.15KTurnover0.10%Turnover RatioLossP/E (Static)93.27MShares1.27552wk High-9.50P/B10.08MFloat Cap0.05052wk Low--Dividend TTM53.05MShs Float13.625Historical High--Div YieldTTM53.63%Amplitude0.050Historical Low0.223Avg Price1Lot Size
Nymox Pharmaceutical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -97.19%76K | -96.76%132K | -47.77%351K | 69.04%1.4M | 69.04%1.4M | -13.94%2.7M | -34.37%4.07M | -23.64%672K | -77.01%830K | -77.01%830K |
| -Cash and cash equivalents | -97.19%76K | -96.76%132K | -47.77%351K | 69.04%1.4M | 69.04%1.4M | -13.94%2.7M | -34.37%4.07M | -23.64%672K | -77.01%830K | -77.01%830K |
| Receivables | -30.00%7K | 11.11%10K | 0.00%10K | -23.08%10K | -23.08%10K | -16.67%10K | -35.71%9K | -33.33%10K | -35.00%13K | -35.00%13K |
| -Other receivables | -30.00%7K | 11.11%10K | 0.00%10K | -23.08%10K | -23.08%10K | -16.67%10K | -35.71%9K | -33.33%10K | -35.00%13K | -35.00%13K |
| Inventory | ---- | ---- | ---- | --0 | --0 | 0.00%34K | 0.00%34K | 0.00%34K | 0.00%34K | 0.00%34K |
| Prepaid assets | 0.00%28K | 0.00%28K | 0.00%28K | 0.00%28K | 0.00%28K | 0.00%28K | 0.00%28K | 0.00%28K | 0.00%28K | 0.00%28K |
| Other current assets | 302.22%543K | 0.00%44K | -50.68%72K | -87.88%16K | -87.88%16K | -22.86%135K | -24.14%44K | 40.38%146K | -34.00%132K | -34.00%132K |
| Total current assets | -77.53%654K | -94.89%214K | -48.20%461K | 40.50%1.46M | 40.50%1.46M | -14.16%2.91M | -33.94%4.19M | -16.12%890K | -73.36%1.04M | -73.36%1.04M |
| Non current assets | ||||||||||
| Net PPE | -93.48%15K | -80.30%56.95K | -67.24%114K | -58.62%168K | -58.62%168K | -50.00%230K | -13.73%289K | -11.68%348K | -9.78%406K | -9.78%406K |
| -Gross PPE | -93.48%15K | -42.43%166.38K | -67.24%114K | -23.13%751K | -23.13%751K | -50.00%230K | -13.73%289K | -11.68%348K | -3.17%977K | -3.17%977K |
| -Accumulated depreciation | ---- | ---109.44K | ---- | -2.10%-583K | -2.10%-583K | ---- | ---- | ---- | -2.15%-571K | -2.15%-571K |
| Total non current assets | -93.48%15K | -80.30%56.95K | -67.24%114K | -58.62%168K | -58.62%168K | -50.00%230K | -13.73%289K | -11.68%348K | -9.78%406K | -9.78%406K |
| Total assets | -78.70%669K | -93.94%271K | -53.55%575K | 12.61%1.63M | 12.61%1.63M | -18.44%3.14M | -32.92%4.47M | -14.91%1.24M | -66.77%1.44M | -66.77%1.44M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | ---- | ---- | ---- | 33.31%1.7M | 33.31%1.7M | ---- | ---- | ---- | -12.39%1.27M | -12.39%1.27M |
| -accounts payable | ---- | ---- | ---- | 33.31%1.7M | 33.31%1.7M | ---- | ---- | ---- | -9.27%1.27M | -9.27%1.27M |
| Current accrued expenses | ---- | ---- | ---- | -16.84%237K | -16.84%237K | ---- | ---- | ---- | -10.66%285K | -10.66%285K |
| Current debt and capital lease obligation | -94.91%11K | 246.98%805K | -50.65%114K | -24.12%173K | -24.12%173K | --216K | 2,477.78%232K | 600.00%231K | 18.13%228K | 18.13%228K |
| -Current debt | ---- | --750K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current capital lease obligation | -94.91%11K | -76.29%55K | -50.65%114K | -24.12%173K | -24.12%173K | --216K | 2,477.78%232K | 600.00%231K | 18.13%228K | 18.13%228K |
| Current liabilities | 9.08%2.57M | 43.74%3.15M | -5.79%2.37M | 17.97%2.11M | 17.97%2.11M | 29.29%2.36M | 32.25%2.19M | 123.21%2.52M | -9.11%1.79M | -9.11%1.79M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --0 | --0 | --0 | --0 | --0 | -97.53%11K | -83.06%52K | -68.05%108K | -30.04%163K | -30.04%163K |
| -Long term capital lease obligation | --0 | --0 | --0 | --0 | --0 | -97.53%11K | -83.06%52K | -68.05%108K | -30.04%163K | -30.04%163K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | -97.53%11K | -83.06%52K | -68.05%108K | -30.04%163K | -30.04%163K |
| Total liabilities | 8.57%2.57M | 40.41%3.15M | -9.67%2.37M | 8.11%2.11M | 8.11%2.11M | 4.41%2.37M | 14.21%2.24M | 79.14%2.63M | -11.33%1.95M | -11.33%1.95M |
| Shareholders'equity | ||||||||||
| Share capital | 0.63%173.35M | -0.34%171.67M | 0.44%171.67M | 4.00%171.67M | 4.00%171.67M | 5.36%172.26M | 6.03%172.26M | 11.90%170.92M | 8.79%165.06M | 8.79%165.06M |
| -common stock | 0.63%173.35M | -0.34%171.67M | 0.44%171.67M | 4.00%171.67M | 4.00%171.67M | 5.36%172.26M | 6.03%172.26M | 11.90%170.92M | 8.79%165.06M | 8.79%165.06M |
| Retained earnings | -2.46%-202.67M | -2.71%-201.64M | -1.46%-200.53M | -3.42%-199.14M | -3.42%-199.14M | -4.24%-197.8M | -5.28%-196.31M | -8.32%-197.65M | -6.96%-192.56M | -6.96%-192.56M |
| Paid-in capital | 1.91%27.42M | 0.81%27.09M | -2.79%27.06M | -2.17%26.99M | -2.17%26.99M | -5.34%26.9M | -8.25%26.87M | -8.14%27.83M | -11.13%27.58M | -11.13%27.58M |
| Other equity interest | ---- | ---- | ---- | ---- | ---- | 0.00%-589K | 0.00%-589K | -322.58%-2.49M | 0.00%-589K | 0.00%-589K |
| Total stockholders'equity | -346.05%-1.9M | -228.90%-2.88M | -29.42%-1.8M | 4.74%-482K | 4.74%-482K | -51.17%773K | -52.58%2.23M | -11,483.33%-1.39M | -123.59%-506K | -123.59%-506K |
| Total equity | -346.05%-1.9M | -228.90%-2.88M | -29.42%-1.8M | 4.74%-482K | 4.74%-482K | -51.17%773K | -52.58%2.23M | -11,483.33%-1.39M | -123.59%-506K | -123.59%-506K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg